Market Snapshot: Dow loses grip on 30,000 as Wall Street awaits FDA vaccine blessing, reacts to jobless claims rise
U.S. stock indexes headed lower early Thursday, ahead of a decision by Food and Drug Administration committee on a vaccine approval, and further talks in Washington on another financial-aid package to combat the impact of the coronavirus pandemic, while U.S. weekly jobless claims rose to a three month high.
